National Sickle Cell Conference

全国镰状细胞会议

基本信息

  • 批准号:
    6941080
  • 负责人:
  • 金额:
    $ 2.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-05-15 至 2006-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This R13 application requests partial support for the Annual Meeting of the National Sickle Cell Program. The meeting, held four of every five years since 1972, now represents a major national and international forum for research in sickle cell disease and an important venue in which basic science investigators, clinicians, service providers, and advocacy groups interact and collaborate. Investigators funded by virtually all of the NIH programs related to sickle cell disease take advantage of the meeting to gather, exchange ideas, and conduct the business of collaborative trials. A total of 450-600 participants are anticipated, including physicians, scientists, nurses, social worker and other health professions, and patient advocates. The Annual Meeting of the National Sickle Cell Program has four major goals: 1. to stimulate and enhance scientific excellence in sickle cell disease research and clinical by fostering exchange of the latest clinical and scientific information; 2. to facilitate communication and collaboration among the NHLBI-funded Comprehensive Sickle Cell Centers (CSCC), other researchers and clinicians, and broader constituencies interested in sickle cell disease; 3. to provide a venue for working meetings of various NIH-funded research programs related to sickle cell disease; 4. to provide a forum in which junior investigators in a variety of fields, including the Sickle Cell Research Scholars funded by NIH through the CSCC, can present their work and interact with each other and with national leaders in sickle cell research. Support is sought for the meetings in April of 2005 and 2006, which represent the 28th and 29* Annual Meetings. The 2005 meeting will be held April 9-13 in Cincinnati, hosted by the Cincinnati Comprehensive Sickle Cell Center, and the 2006 meeting will be hosted in Memphis by the St. Jude Children's Research Hospital Comprehensive Sickle Cell Center, Winfred Wang, Director. The Steering Committee of the CSCC will oversee planning of the conference. The requested funds will cover invited speakers, facility costs, audiovisual expenses, and program printing costs, representing approximately one third of the overall costs of the meeting. The remainder of the funds will be derived from registration fees and donations from corporate participants and sponsors.
描述(由申请人提供):此R13申请要求部分支持国家镰状细胞计划年会。该会议自1972年以来每五年举行一次,现在是镰状细胞病研究的主要国家和国际论坛,也是基础科学研究人员,临床医生,服务提供者和倡导团体互动和合作的重要场所。几乎所有与镰状细胞病相关的NIH项目资助的研究人员都利用这次会议来收集、交流想法,并开展合作试验。预计共有450-600人参加,包括医生、科学家、护士、社会工作者和其他卫生专业人员以及病人倡导者。 全国镰状细胞病计划年会有四个主要目标: 1. 通过促进最新临床和科学信息的交流,激励和提高镰状细胞病研究和临床的科学成就; 2. 促进NHLBI资助的综合镰状细胞中心(CSCC),其他研究人员和临床医生以及对镰状细胞病感兴趣的更广泛的支持者之间的沟通和合作; 3.为各种NIH资助的镰状细胞病相关研究项目的工作会议提供场所; 4.为各个领域的初级研究人员提供一个论坛,包括由NIH通过CSCC资助的镰状细胞研究学者,可以展示他们的工作,并与镰状细胞研究的国家领导人相互交流。 2005年4月和2006年4月举行的第28次和第29次 * 年度会议需要得到支助。2005年会议将于4月9日至13日在辛辛那提举行,由辛辛那提综合镰状细胞中心主办,2006年会议将在孟菲斯举行,由圣裘德儿童研究医院综合镰状细胞中心主任Winfred Wang主办。CSCC的指导委员会将监督会议的规划。所要求的资金将用于支付应邀发言者、设施费用、视听费用和方案印刷费用,约占会议总费用的三分之一。其余资金将来自注册费和企业参与者和赞助商的捐款。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Clinton H Joiner其他文献

Clinton H Joiner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Clinton H Joiner', 18)}}的其他基金

Research Training in Pediatric Non-Malignant Hematology
儿科非恶性血液学研究培训
  • 批准号:
    10472492
  • 财政年份:
    2018
  • 资助金额:
    $ 2.5万
  • 项目类别:
Research Training in Pediatric Non-Malignant Hematology
儿科非恶性血液学研究培训
  • 批准号:
    10555521
  • 财政年份:
    2018
  • 资助金额:
    $ 2.5万
  • 项目类别:
Research Training in Pediatric Non-Malignant Hematology
儿科非恶性血液学研究培训
  • 批准号:
    10201726
  • 财政年份:
    2018
  • 资助金额:
    $ 2.5万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    8150166
  • 财政年份:
    2010
  • 资助金额:
    $ 2.5万
  • 项目类别:
GENETIC MANIPULATION OF RED CELL VOLUME REGULATION
红细胞体积调节的基因调控
  • 批准号:
    8150163
  • 财政年份:
    2010
  • 资助金额:
    $ 2.5万
  • 项目类别:
National Sickle Cell Conference
全国镰状细胞会议
  • 批准号:
    7216548
  • 财政年份:
    2005
  • 资助金额:
    $ 2.5万
  • 项目类别:
Cincinnati Comprehensive Sickle Cell Center
辛辛那提综合镰状细胞中心
  • 批准号:
    6530540
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
Comprehensive Sickle Cell Center
综合镰状细胞中心
  • 批准号:
    7343525
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
In Vivo Hydration Changes in Hemoglobin SS and SC Cells
血红蛋白 SS 和 SC 细胞的体内水合变化
  • 批准号:
    6782218
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
Cincinnati Comprehensive Sickle Cell Center
辛辛那提综合镰状细胞中心
  • 批准号:
    7463051
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:

相似海外基金

Small Molecule Therapeutics for Sickle Cell Anemia
镰状细胞性贫血的小分子疗法
  • 批准号:
    10601679
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
  • 批准号:
    10564553
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Developmental Pharmacology of Hydroxyurea Across the Age Span for the Treatment of Sickle Cell Anemia
不同年龄段羟基脲治疗镰状细胞性贫血的发育药理学
  • 批准号:
    10382052
  • 财政年份:
    2022
  • 资助金额:
    $ 2.5万
  • 项目类别:
OVARIAN RESERVE IN POST-MENARCHAL FEMALES WITH SICKLE CELL ANEMIA
患有镰状细胞性贫血的初潮后女性的卵巢储备
  • 批准号:
    10690200
  • 财政年份:
    2022
  • 资助金额:
    $ 2.5万
  • 项目类别:
Developmental Pharmacology of Hydroxyurea Across the Age Span for the Treatment of Sickle Cell Anemia
不同年龄段羟基脲治疗镰状细胞性贫血的发育药理学
  • 批准号:
    10551233
  • 财政年份:
    2022
  • 资助金额:
    $ 2.5万
  • 项目类别:
Investigating the interplay between Sickle Cell Anemia and Malaria at the epidemiological and molecular levels.
在流行病学和分子水平上研究镰状细胞性贫血和疟疾之间的相互作用。
  • 批准号:
    463824
  • 财政年份:
    2022
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Operating Grants
Microvascular Cerebral Blood Flow Monitoring with Diffuse Correlation Spectroscopy in Sickle Cell Anemia Children
镰状细胞性贫血儿童的弥散相关光谱微血管脑血流监测
  • 批准号:
    10597513
  • 财政年份:
    2021
  • 资助金额:
    $ 2.5万
  • 项目类别:
The Impact of Cerebral Metabolic Stress on the Development of the Structural and Functional Connectome in Pediatric Sickle Cell Anemia
脑代谢应激对小儿镰状细胞贫血症结构和功能连接体发育的影响
  • 批准号:
    10179749
  • 财政年份:
    2021
  • 资助金额:
    $ 2.5万
  • 项目类别:
Opportunities to optimize the receipt of preventive services among children with sickle cell anemia: A Mixed Methods Approach
优化镰状细胞性贫血儿童预防服务接受的机会:混合方法
  • 批准号:
    10469404
  • 财政年份:
    2021
  • 资助金额:
    $ 2.5万
  • 项目类别:
The Impact of Cerebral Metabolic Stress on the Development of the Structural and Functional Connectome in Pediatric Sickle Cell Anemia
脑代谢应激对小儿镰状细胞贫血症结构和功能连接体发育的影响
  • 批准号:
    10594416
  • 财政年份:
    2021
  • 资助金额:
    $ 2.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了